Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 43% ± 13% | |
peripheral blood | 17 studies | 41% ± 14% | |
brain | 14 studies | 33% ± 14% | |
intestine | 11 studies | 36% ± 14% | |
kidney | 9 studies | 34% ± 11% | |
eye | 9 studies | 38% ± 17% | |
liver | 7 studies | 40% ± 21% | |
bone marrow | 5 studies | 30% ± 11% | |
uterus | 5 studies | 46% ± 18% | |
lymph node | 5 studies | 45% ± 9% | |
pancreas | 4 studies | 59% ± 14% | |
adipose | 4 studies | 23% ± 10% | |
prostate | 4 studies | 35% ± 10% | |
breast | 4 studies | 55% ± 7% | |
placenta | 3 studies | 55% ± 7% | |
heart | 3 studies | 18% ± 1% | |
adrenal gland | 3 studies | 42% ± 16% | |
esophagus | 3 studies | 43% ± 15% | |
skin | 3 studies | 38% ± 14% | |
thymus | 3 studies | 51% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 11974.11 | 459 / 459 | 100% | 92.11 | 1118 / 1118 |
esophagus | 100% | 12298.89 | 1445 / 1445 | 100% | 93.64 | 183 / 183 |
ovary | 100% | 9791.56 | 180 / 180 | 100% | 56.23 | 430 / 430 |
pancreas | 100% | 7241.15 | 328 / 328 | 100% | 67.92 | 178 / 178 |
brain | 100% | 12437.58 | 2641 / 2642 | 100% | 107.89 | 705 / 705 |
intestine | 100% | 14444.23 | 966 / 966 | 100% | 80.90 | 526 / 527 |
prostate | 100% | 10534.47 | 245 / 245 | 100% | 63.38 | 501 / 502 |
liver | 100% | 16428.39 | 226 / 226 | 100% | 59.63 | 405 / 406 |
lung | 100% | 10788.81 | 576 / 578 | 100% | 86.58 | 1155 / 1155 |
stomach | 100% | 10717.69 | 359 / 359 | 100% | 76.16 | 285 / 286 |
bladder | 100% | 12539.38 | 21 / 21 | 100% | 77.60 | 502 / 504 |
uterus | 100% | 10858.02 | 170 / 170 | 100% | 80.12 | 457 / 459 |
thymus | 100% | 12674.04 | 653 / 653 | 99% | 75.89 | 601 / 605 |
kidney | 100% | 11812.90 | 89 / 89 | 99% | 59.51 | 890 / 901 |
adrenal gland | 100% | 13303.30 | 258 / 258 | 97% | 61.23 | 222 / 230 |
skin | 100% | 10651.57 | 1807 / 1809 | 96% | 73.93 | 453 / 472 |
adipose | 100% | 12964.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 70.17 | 29 / 29 |
muscle | 100% | 14985.26 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 12191.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 79.22 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 56.24 | 1 / 1 |
blood vessel | 100% | 9558.21 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 8070.36 | 833 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 39.82 | 69 / 80 |
peripheral blood | 86% | 6164.30 | 798 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001732 | Biological process | formation of cytoplasmic translation initiation complex |
GO_0006446 | Biological process | regulation of translational initiation |
GO_0042255 | Biological process | ribosome assembly |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0005525 | Molecular function | GTP binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0005092 | Molecular function | GDP-dissociation inhibitor activity |
GO_0071074 | Molecular function | eukaryotic initiation factor eIF2 binding |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF5 |
Protein name | Eukaryotic translation initiation factor 5 Eukaryotic translation initiation factor 5 (eIF-5) |
Synonyms | |
Description | FUNCTION: Component of the 43S pre-initiation complex (43S PIC), which binds to the mRNA cap-proximal region, scans mRNA 5'-untranslated region, and locates the initiation codon . In this complex, acts as a GTPase-activating protein, by promoting GTP hydrolysis by eIF2G (EIF2S3) . During scanning, interacts with both EIF1 (via its C-terminal domain (CTD)) and EIF1A (via its NTD) . This interaction with EIF1A contributes to the maintenance of EIF1 within the open 43S PIC . When start codon is recognized, EIF5, via its NTD, induces eIF2G (EIF2S3) to hydrolyze the GTP . Start codon recognition also induces a conformational change of the PIC to a closed state . This change increases the affinity of EIF5-CTD for EIF2-beta (EIF2S2), which allows the release, by an indirect mechanism, of EIF1 from the PIC . Finally, EIF5 stabilizes the PIC in its closed conformation . . |
Accessions | H0YK29 ENST00000559532.5 Q6IBU0 Q05DF3 ENST00000558506.1 H0YK11 ENST00000559130.5 P55010 ENST00000216554.8 ENST00000558265.5 H0YN40 Q32Q19 ENST00000561325.5 H0YLZ1 H0YM54 ENST00000558316.5 ENST00000560763.5 ENST00000560338.5 ENST00000392715.6 H0YMJ8 |